GO:0007155 cell adhesion: Mechanism, Genes, Functions

Cell adhesion (GO:0007155) is a fundamental biological process defined as the attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. This process is essential for tissue architecture, cell signaling, migration, and survival, and it is mediated by a diverse set of surface receptors and adhesion complexes. Cell adhesion molecules (CAMs) encompass several families, including cadherins, integrins, selectins, and immunoglobulin superfamily members, each contributing to specific adhesive functions. Beyond structural roles, adhesion receptors transduce mechanical and biochemical signals that influence cell fate and behavior. Research on cell adhesion has expanded from descriptive morphology to mechanistic and translational studies. For example, tight junction-associated adhesion is now recognized as a dynamic signaling hub with new functional aspects. In cancer, altered cell adhesion and glycosylation promote immune suppression and metastasis, highlighting adhesion as a therapeutic vulnerability. Cell adhesion molecules also play critical roles in endocrine-related cancers, where they influence proliferation, invasion, and endocrine resistance. In the immune system, mast cell adhesion is finely regulated to control tissue residency and effector functions. Understanding cell adhesion at the molecular, cellular, and tissue levels requires integrated approaches. This article synthesizes authoritative GO annotation and published literature to outline the mechanisms, key genes, disease links, and research methods relevant to GO:0007155. It is intended for researchers seeking a concise, citable overview to guide experimental design and interpretation.

In our own words, GO:0007155 cell adhesion is the process through which a cell physically attaches to another cell or to an extracellular matrix substrate using specialized cell adhesion molecules. This process is distinct from cell-cell signaling or cell migration, although it is often coupled to them. The QuickGO definition emphasizes attachment via cell adhesion molecules, and the synonym 'single organism cell adhesion' underscores that the process occurs within an organism without necessarily implying a multicellular developmental context. Cell adhesion is a biological process (GO aspect: biological_process) and is fundamental to tissue integrity, immune function, and development.

Cell adhesion is central to virtually every aspect of multicellular life, from embryonic development to immune defense and tissue homeostasis. Disruption of adhesion contributes to cancer progression, where altered adhesion and glycosylation promote immune suppression and metastasis. In endocrine-related cancers, cell adhesion molecules modulate tumor growth and invasion, offering potential biomarkers and therapeutic targets. Adhesion is also critical for immune cell function, as exemplified by mast cell adhesion in allergic and inflammatory responses. In the nervous system, synaptic cell adhesion molecules organize synaptic structure and plasticity, with implications for neurodevelopmental and neurodegenerative disorders. Thus, understanding cell adhesion mechanisms is essential for both basic biology and translational medicine.

The following genes encode major cell adhesion molecules and related proteins that are central to GO:0007155, based on published literature.

Cell adhesion is regulated at multiple levels, including transcriptional control of adhesion molecule expression, post-translational modifications such as glycosylation, and dynamic protein-protein interactions. Altered glycosylation of adhesion molecules can promote cancer immune suppression and metastasis. Tight junction adhesion is regulated by signaling pathways that control assembly and disassembly in response to environmental cues. In mast cells, adhesion is regulated by cytokines and chemokines that modulate integrin affinity. Plasticity in cell adhesion during tumor progression involves reversible changes in adhesion molecule expression and function. Naturally occurring inhibitors can block specific adhesion interactions, providing insights into regulatory mechanisms.

Altered cell adhesion is a hallmark of cancer progression. Loss of E-cadherin-mediated adhesion promotes epithelial-mesenchymal transition and metastasis, while altered glycosylation of adhesion molecules contributes to immune suppression. Cell adhesion molecules are also implicated in endocrine-related cancers, where they influence tumor growth, invasion, and response to therapy. Plasticity in cell adhesion allows tumor cells to adapt to different microenvironments during metastatic dissemination.

Cell adhesion molecules are critical for immune cell trafficking and function. Mast cell adhesion is essential for their localization and effector responses in allergic and inflammatory diseases. Selectins and integrins mediate leukocyte adhesion to endothelium, and dysregulation contributes to chronic inflammation and autoimmune conditions. Targeting adhesion molecules is a therapeutic strategy in inflammatory diseases.

Synaptic cell adhesion molecules organize synaptic structure and function, and their dysfunction is linked to neurodevelopmental and neurodegenerative disorders. Neural cell adhesion molecules such as NCAM1 and L1CAM are studied for their roles in synaptic plasticity and cognitive function. Tight junction adhesion in the blood-brain barrier also affects neurological health.

CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of adhesion gene function. Knockout of CDH1 or ITGB1 can reveal their roles in adhesion and migration. Point mutations can test the importance of specific residues in adhesion molecule function. Knock-in of tagged adhesion proteins allows visualization of localization and dynamics. Overexpression models can assess gain-of-function effects in cancer and immune cells.

Adhesion assays measure the ability of cells to attach to specific substrates or to other cells. These include cell-matrix adhesion assays, cell-cell aggregation assays, and flow-based adhesion assays for selectins and integrins. Such assays are used to quantify the effects of genetic perturbations on adhesion strength and specificity.

Advanced imaging techniques such as live-cell microscopy and super-resolution imaging visualize adhesion complex assembly and dynamics. Proteomics approaches identify adhesion complex components and post-translational modifications, including glycosylation changes that affect adhesion. These methods provide mechanistic insights into how adhesion molecules function in health and disease.

CRISPR library screening enables unbiased identification of genes that regulate cell adhesion. Pooled screens can be designed to select for cells with altered adhesion properties, revealing novel adhesion regulators. Bioinformatics analysis of screening data identifies enriched pathways and networks, accelerating target discovery.

Researchers studying cell adhesion-related genes often need to determine whether a candidate gene is causally involved in adhesion, migration, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of adhesion genes in relevant biological contexts.

Cell adhesion (GO:0007155) is a fundamental biological process that governs how cells interact with their environment and with each other. It is mediated by diverse families of adhesion molecules and is dynamically regulated in development, immunity, and disease. Dysregulation of adhesion contributes to cancer progression, immune disorders, and neurological conditions, making it a rich area for research and therapeutic targeting. Advances in CRISPR-based models and screening technologies now enable precise functional dissection of adhesion genes, accelerating the translation of basic discoveries into clinical applications.